JCB logo
PeproTech: Cell Culture Supplements
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

A correction to this article has been published: J. Cell Biol. 143 (5) 1413
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 662K)
Right arrow PPT slides of all figures
Right arrow Correction (v143,p1413)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gimond, C.
Right arrow Articles by Sonnenberg, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gimond, C.
Right arrow Articles by Sonnenberg, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

© The Rockefeller University Press, 0021-9525/1998//253 $5.00
The Journal of Cell Biology, Volume 143, Number 1, , 1998 253-266


Regular Articles

Cre-loxP–mediated Inactivation of the {alpha}6A Integrin Splice Variant In Vivo: Evidence for a Specific Functional Role of {alpha}6A in Lymphocyte Migration but Not in Heart Development



Clotilde Gimond, Christian Baudoin, Ronald van der Neut, Duco Kramer, Jero Calafat, and Arnoud Sonnenberg

Division of Cell Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands

Two splice variants of the {alpha}6 integrin subunit, {alpha}6A and {alpha}6B, with different cytoplasmic domains, have previously been described. While {alpha}6B is expressed throughout the development of the mouse, the expression of {alpha}6A begins at 8.5 days post coitum and is initially restricted to the myocardium. Later in ontogeny, {alpha}6A is found in various epithelia and in certain cells of the immune system. In this study, we have investigated the function of {alpha}6A in vivo by generating knockout mice deficient for this splice variant. The Cre- loxP system of the bacteriophage P1 was used to specifically remove the exon encoding the cytoplasmic domain of {alpha}6A in embryonic stem cells, and the deletion resulted in the expression of {alpha}6B in all tissues that normally express {alpha}6A. We show that {alpha}6A–/– mice develop normally and are fertile. The substitution of {alpha}6A by {alpha}6B does not impair the development and function of the heart, hemidesmosome formation in the epidermis, or keratinocyte migration. Furthermore, T cells differentiated normally in {alpha}6A–/– mice. However, the substitution of {alpha}6A by {alpha}6B leads to a decrease in the migration of lymphocytes through laminin-coated Transwell filters and to a reduction of the number of T cells isolated from the peripheral and mesenteric lymph nodes. Lymphocyte homing to the lymph nodes, which involves various types of integrin–ligand interactions, was not affected in the {alpha}6A knockout mice, indicating that the reduced number of lymph node cells could not be directly attributed to defects in lymphocyte trafficking. Nevertheless, the expression of {alpha}6A might be necessary for optimal lymphocyte migration on laminin in certain pathological conditions.

Key Words: integrin • laminin receptor • knockout • migration • lymphocyte



Abbreviations used in this paper: dpc, days post coitum; ES, embryonic stem.

All of the ES cell work was carried out in the division of Molecular Genetics (Head Prof. Dr. A. Berns) at the Netherlands Cancer Institute. This work was supported by a fellowship from the European Commission (ERB4050PL930847) to C. Gimond, a Marie Curie Research training grant from the European Commission (ERBFMBICT961823) to C. Baudoin, and grants from the Netherlands Heart Foundation (NHS 96.006) and the Netherlands Organization for Scientific Research (NWO 900-511-043).

Address all correspondence to Arnoud Sonnenberg, Division of Cell Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Tel.: (31) 20 512 1942. Fax: (31) 20 512 1944. E-mail: asonn{at}nki.nl

Ronald van der Neut's present address is INSERM U434, 27 rue Juliette Dodu, 75010 Paris, France.



Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents